CHRS
Coherus BioSciences Inc
1.10$
+5.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 39.7% | 6,991.7% | 33,400.6% | 2,379.9% | 3,055.6% | 1,987.8% | – | – | – | – | 6.0% | 0.7% | 5.8% | 6.3% | 5.9% | 7.5% | 7.9% | 10.6% | 9.0% | 19.1% | 25.8% | 16.5% | 15.6% | 18.7% | 77.6% | 31.3% | 52.0% | 42.3% | 43.9% | 92.4% | 62.3% | 45.5% | 29.3% | 62.5% | 48.7% | 43.0% | 40.5% | 38.8% | 38.1% | 29.6% | 36.4% | |
| 60.3% | -6,891.7% | -33,300.6% | -2,279.9% | -3,055.6% | -1,987.8% | – | – | – | – | 94.0% | 99.3% | 94.2% | 93.7% | 94.1% | 92.5% | 92.1% | 89.4% | 91.0% | 80.9% | 74.2% | 83.5% | 84.4% | 81.3% | 22.4% | 68.7% | 48.0% | 57.7% | 56.1% | 7.6% | 37.7% | 54.5% | 70.7% | 37.5% | 51.3% | 57.0% | 59.5% | 61.2% | 61.9% | 70.4% | 63.6% | |
| 39.7% | 6,991.7% | 33,400.6% | 2,473.1% | 3,055.6% | 2,023.7% | – | – | – | – | 50.6% | 22.6% | 19.3% | 28.2% | 28.5% | 19.3% | 34.2% | 40.4% | 245.1% | 62.5% | 65.6% | 69.2% | 137.9% | 69.2% | 100.8% | 64.0% | 105.3% | 39.6% | 34.4% | 28.8% | 1,231.5% | 32.0% | 30.6% | 39.2% | 306.8% | 246.6% | 227.2% | 235.9% | 167.8% | 149.9% | 193.3% | |
| 8.4% | 1,812.1% | 11,678.9% | 1,687.0% | 1,002.8% | 962.6% | – | – | – | – | 88.1% | 43.7% | 28.5% | 25.5% | 30.4% | 25.1% | 28.2% | 30.7% | 47.4% | 46.0% | 48.4% | 56.4% | 81.1% | 85.2% | 98.7% | 95.1% | 151.5% | 76.9% | 64.7% | 40.1% | 2,449.4% | 54.1% | 49.1% | 43.8% | 342.5% | 253.9% | 215.5% | 185.2% | 187.7% | 146.5% | 181.8% | |
| 48.0% | 8,803.8% | 45,079.5% | 4,160.1% | 4,058.4% | 2,986.2% | – | – | – | – | 138.7% | 66.3% | 47.8% | 57.3% | 58.9% | 44.4% | 62.4% | 74.6% | 292.5% | 108.5% | 113.9% | 137.4% | 219.0% | 154.4% | 199.5% | 182.2% | 256.8% | 116.5% | 99.1% | 82.9% | 2,974.7% | 86.1% | 79.7% | 115.5% | 649.2% | 500.6% | 424.5% | 421.1% | 355.5% | 296.3% | 371.0% | |
| 52.0% | -8,703.8% | -44,979.5% | -4,060.1% | -4,058.4% | -2,986.2% | – | – | – | – | -44.7% | 33.0% | 46.4% | 36.4% | 35.2% | 48.1% | 29.7% | 14.9% | -201.6% | -27.6% | -39.7% | -53.9% | -134.6% | -73.2% | -177.1% | -113.5% | -208.9% | -58.8% | -42.9% | -75.3% | -2,937.0% | -31.6% | -9.0% | -78.0% | -597.9% | -443.6% | -365.0% | -359.9% | -293.7% | -226.0% | -307.4% | |
| 1.5% | 280.7% | 1,475.8% | 170.9% | 171.5% | 154.2% | – | – | – | – | 11.4% | 5.3% | 4.0% | 3.6% | 3.8% | 4.0% | 5.0% | 5.1% | 6.8% | 6.6% | 7.0% | 7.9% | 14.9% | 10.9% | 16.6% | 20.7% | 29.9% | 16.9% | 13.8% | 11.6% | 481.6% | 8.2% | 7.6% | 9.9% | 28.3% | 22.2% | 20.1% | 17.6% | 17.8% | 16.2% | 17.8% | |
| 51.5% | -8,998.1% | -46,473.3% | -3,971.5% | -4,228.9% | -3,153.5% | – | – | – | – | -53.9% | 28.3% | 42.9% | 33.3% | 31.4% | 44.5% | 24.8% | 9.7% | -208.3% | -34.1% | -46.7% | -62.3% | -159.8% | -83.4% | -190.8% | -129.8% | -233.5% | -73.0% | -53.7% | -87.0% | -2,947.8% | -19.9% | -15.2% | -93.6% | -623.7% | -437.5% | -384.7% | -363.6% | -300.0% | -233.1% | -316.4% | |
| 2.4% | 50.7% | 1,430.4% | 425.7% | 172.2% | 7.3% | – | – | – | – | 13.6% | 0.1% | 0.8% | 1.7% | 0.8% | 1.0% | 0.2% | 1.0% | 6.9% | 6.6% | 7.0% | 7.9% | 25.2% | 10.2% | 13.7% | 16.3% | -2.9% | 19.7% | -0.5% | -11.6% | 63.4% | – | – | -93.6% | 120.7% | -3,341.4% | -77.7% | -68.3% | 11.3% | -88.9% | -57.0% | |
| 51.5% | -8,995.4% | -46,446.0% | -3,966.7% | -4,228.6% | -3,153.4% | – | – | – | – | -53.9% | 28.2% | 42.1% | 31.7% | 30.6% | 43.5% | 24.6% | 8.8% | -208.3% | -34.1% | -46.7% | -62.3% | -159.8% | -83.4% | -190.8% | -129.8% | -233.5% | -73.0% | -53.2% | -87.0% | 4,457.3% | -19.9% | -15.2% | -93.6% | -744.4% | -403.1% | -303.4% | -292.4% | -308.2% | -144.2% | -257.1% | |
| 53.4% | -8,623.0% | -44,460.2% | -3,740.5% | -4,003.2% | -2,939.8% | – | – | – | – | -40.7% | 33.8% | 47.6% | 37.8% | 35.8% | 49.0% | 30.4% | 15.6% | -200.5% | -26.6% | -38.6% | -53.3% | -143.6% | -71.0% | -172.0% | -106.8% | -200.6% | -54.6% | -37.7% | -74.3% | -2,747.4% | -9.8% | -5.4% | -81.9% | -581.7% | -405.4% | -356.3% | -338.9% | -275.1% | -210.8% | -291.5% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.